SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-23-012232
Filing Date
2023-08-14
Accepted
2023-08-14 17:52:24
Documents
1
Period of Report
2023-08-10

Document Format Files

Seq Description Document Type Size
1 form4-08142023_090802.html 4  
1 form4-08142023_090802.xml 4 3925
  Complete submission text file 0001415889-23-012232.txt   5432
Mailing Address 375 PHEASANT RUN NEWTOWN PA 18940
Business Address 375 PHEASANT RUN NEWTOWN PA 18940 267-759-3681
Onconova Therapeutics, Inc. (Issuer) CIK: 0001130598 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SICOR INC 19 HUGHES IRVINE CA 92618-1902
Business Address
STOVER JACK E (Reporting) CIK: 0001203603 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36020 | Film No.: 231172395